BUSINESS
Sawai, Nichi-Iko to Consolidate 15 APIs as Sector Tackles Small-Lot Production
Two of Japan’s largest generic makers are joining hands to address the industry’s chronic inefficiencies stemming from multi-product small-lot production. Sawai Pharmaceutical and Nichi-Iko Pharmaceutical revealed on September 10 that they will consolidate 30 generic products across 15 APIs as…
To read the full story
Related Article
- Sawai Cleared to Manufacture Nichi-Iko’s Lipitor Generic
June 26, 2026
BUSINESS
- Takeda Turns the Page to Kim’s “10-Year” Era, Betting on New Drugs and AI
June 26, 2026
- Sangamo Files Chapter 11, Astellas and Lilly Eye Key Assets
June 26, 2026
- Otsuka’s Centanafadine Meets PIII Goal in ADHD Patients with Anxiety
June 26, 2026
- Shionogi Welcomes Government Roadmap’s Focus on Infectious Diseases
June 26, 2026
- Sawai Cleared to Manufacture Nichi-Iko’s Lipitor Generic
June 26, 2026
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…





